Related Experiment Video
Updated: Jun 22, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Genomic view of factors leading to plaque instability
Sonny Dandona1, Robert Roberts
1University of Ottawa Heart Institute, Ontario, Canada. sdandona@ottawaheart.ca
Insights
Identifying DNA variants linked to atherosclerotic plaque rupture is key to predicting sudden cardiac death risk in seemingly healthy individuals. Genome-wide studies will improve this risk assessment.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Pathology
Background:
- Coronary artery disease (CAD) manifests diversely, stemming from atherosclerotic plaque buildup.
- Sudden, unexpected death in healthy individuals is a feared complication of CAD.
- Plaque rupture and subsequent thrombosis, even from minor lesions, cause many such deaths.
Purpose of the Study:
- To identify DNA sequence variants associated with atherosclerotic plaque rupture.
- To enable screening of populations at increased risk for sudden cardiac death.
Main Methods:
- Current phenotyping methods are insufficient for detecting predisposition to plaque rupture.
- Genome-wide association studies (GWAS) are proposed for future investigation.
- Refined imaging and large patient cohorts are needed to facilitate genomic approaches.
Main Results:
- No specific results are detailed in the abstract.
- The abstract outlines a research direction rather than presenting findings.
Conclusions:
- Identifying genetic predispositions to plaque rupture is crucial for preventing sudden cardiac death.
- Advanced imaging and large-scale genomic studies are necessary to achieve this goal.
Abstract:
The manifestations of coronary artery disease are varied. They all arise as a consequence of the deposition of atherosclerotic plaque within the vessel wall. The most feared sequela of coronary artery disease is sudden and unexpected death in the ostensibly healthy patient. Plaque rupture of hemodynamically insignificant atherosclerotic plaques and ensuing thrombosis is likely responsible for a large proportion of such deaths. Identifying populations at increased risk for sudden death would represent a major advance. Such screening is contingent upon identification of DNA sequence variants that predispose individuals to plaque rupture. Phenotyping is not sufficiently nuanced to detect such variants on a large scale, so we are limited to end points that are crude surrogates for plaque rupture. As imaging modalities are refined and our ability to recruit large numbers of appropriate patients is facilitated by the formation of alliances, our ability to probe this conundrum via a genome-wide approach will improve.
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Inflammation
Alzheimer Disease ll: Pathophysiology
Alzheimer Disease l: Introduction
